OFIX vs PATH
Orthofix Medical Inc (OFIX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Orthofix Medical Inc (OFIX) is a medical devices company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported OFIX revenue for 2024-12-31 was $799.5M. Net income was -$126.0M. Revenue was up 7.1% from 2023-12-31 to 2024-12-31. OFIX currently screens at market cap $438.0M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
OFIX currently screens at market cap $438.0M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the OFIX and PATH stock pages for the full models.
Not investment advice.